These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28367844)

  • 1. Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome.
    Kawabata M; Goya M; Sasaki T; Maeda S; Yagishita A; Shirai Y; Kaneko M; Shiohira S; Isobe M; Hirao K
    Circ J; 2017 Jun; 81(7):981-987. PubMed ID: 28367844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Tachibana M; Nishii N; Morita H; Nakagawa K; Watanabe A; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1454-1459. PubMed ID: 28800177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.
    Conte G; Kawabata M; de Asmundis C; Taravelli E; Petracca F; Ruggiero D; Caputo ML; Regoli F; Chierchia GB; Chiodini A; Del Bufalo A; Moccetti T; Goya M; Hirao K; Vicentini A; De Ferrari GM; Brugada P; Auricchio A
    Europace; 2018 Jul; 20(7):1188-1193. PubMed ID: 28340026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.
    von Hafe P; Faria B; Dias G; Cardoso F; Alves MJ; Alves A; Rodrigues B; Ribeiro S; Sanfins V; Lourenço A
    Rev Port Cardiol (Engl Ed); 2021 Jan; 40(1):33-38. PubMed ID: 33436324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
    Russo V; Caturano A; Guerra F; Migliore F; Mascia G; Rossi A; Nesti M; Santobuono VE; Attena E; Tola G; Sciarra L; Conte G; Paoletti Perini A; Francia P; Dendramis G; Palamà Z; Albani S; Ottonelli Ghidini A; Calò L; D'Onofrio A; Baldi E;
    Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators.
    Miwa N; Nagata Y; Yamaguchi T; Nagase M; Sasaki T; Nozato T; Ashikaga T; Goya M; Hirao K
    Heart Rhythm; 2019 Jun; 16(6):913-920. PubMed ID: 30616021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Kusano K
    Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan.
    Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
    Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.
    Casu G; Silva E; Bisbal F; Viola G; Merella P; Lorenzoni G; Motta G; Bandino S; Berne P
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1704-1711. PubMed ID: 33928706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of subcutaneous implantable cardioverter-defibrillator based on template ECG screening and ineligible surface ECG predicting factors in patients with hypertrophic cardiomyopathy in China.
    Guo L; Zhang M; Hu M; Wang B; Wang J; Zuo L; Yang W; Liu B; Liu L
    Heart Vessels; 2019 May; 34(5):851-859. PubMed ID: 30465278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome.
    Dendramis G; Brugada P
    Heart Rhythm; 2023 Feb; 20(2):274-281. PubMed ID: 36162769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of routine right parasternal electrocardiographic screening in assessing eligibility for subcutaneous implantable cardioverter-defibrillator.
    Arias MA; Pachón M; Sánchez-Iglesias I; Loughlin G; Martín-Sierra C; Puchol A; Sabatel F; Rodríguez-Padial L
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):103-111. PubMed ID: 31724763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Implantable Defibrillators for Asymptomatic Brugada Syndrome: A Decision-Analytic Model.
    Khurshid S; Chen W; Bode WD; Wasfy JH; Chhatwal J; Lubitz SA
    J Am Heart Assoc; 2021 Aug; 10(16):e021144. PubMed ID: 34387130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.
    Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.
    Rodríguez-Mañero M; de Asmundis C; Sacher F; Arbelo E; Probst V; Castro-Hevia J; Maury P; Rollin A; Lambiase P; García-Bolao I; Chierchia GB; Fukushima Kusano K; Gourraud JB; Schilling R; Kamakura T; Martínez-Sande JL; Haïssaguerre M; González-Juanatey JR; Brugada J; Brugada P
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):792-8. PubMed ID: 26041387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    Hernandez-Ojeda J; Arbelo E; Borras R; Berne P; Tolosana JM; Gomez-Juanatey A; Berruezo A; Campuzano O; Sarquella-Brugada G; Mont L; Brugada R; Brugada J
    J Am Coll Cardiol; 2017 Oct; 70(16):1991-2002. PubMed ID: 29025556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Clinical Impact of Early Repolarization Pattern and QRS-Fragmentation in High-Risk Patients With Brugada Syndrome.
    Conte G; de Asmundis C; Sieira J; Ciconte G; Di Giovanni G; Chierchia GB; Casado-Arroyo R; Baltogiannis G; Ströker E; Irfan G; Pappaert G; Auricchio A; Brugada P
    Circ J; 2016 Sep; 80(10):2109-16. PubMed ID: 27558008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.